by
According to the Foreclaro Global Research, the
Global
Synthetic Biology Market size was valued at USD 18239.3 million in 2024. The report “Global
Synthetic Biology Market Segmentation By Tool (Oligonucleotides
and Synthetic DNA {Oligonucleotides/Primers, Synthetic Genes, DNA Libraries}, Enzymes
{Polymerases, Ligases, Nucleases, Restriction Enzymes}, Chassis Organisms {Microbial,
Mammalian Cells, Other Host Organisms}, Software & Design Tools, {Bioinformatics
Platforms, DNA Design & Sequencing Software}), By Technology (Gene
Synthesis, Genome Engineering, Sequencing, Bioinformatics, Site-Directed
Mutagenesis, Cloning & Assembly, Microfluidics, Phage Engineering), By
Application (Healthcare {Therapeutics, Drug Discovery & Development, Diagnostics},
Industrial Applications {Biofuels & Renewable Energy, Bioplastics &
Bio-based Materials, Bio-Manufacturing}, Food & Agriculture, Environmental
Applications), By End User (Biotechnology and Pharmaceutical Companies, Academic
& Research Institutes, Food & Agricultural Companies, Energy &
Chemical Companies, Contract Research & Manufacturing Organizations
(CROs/CMOs))- Industry
Trends and Forecast to 2033” gives a detailed insight into current market dynamics and provides
analysis on future market growth.
Synthetic biology is an interdisciplinary area
that mixes biology, engineering, and computational sciences to design,
redesign, and assemble new organic structures and organisms for beneficial
purposes. It allows the introduction of artificial DNA, engineered microbes,
and novel biomolecules, which could deal with worldwide demanding situations in
healthcare, energy, agriculture, and the environment. The area has won momentum
with improvements in DNA sequencing, synthesis, and gene-modifying equipment
like CRISPR, which have drastically decreased costs and stepped forward
efficiency. In healthcare, artificial biology is revolutionizing drug
discovery, vaccine improvement, and gene therapies; at the same time as in
agriculture, it helps the improvement of high-yield, pest-resistant plants and
biofertilizers. Industrial packages encompass biofuels, bioplastics, and
environmentally sustainable production processes. Additionally, artificial
biology is being carried out to carbon seize and pollutants control, making it
a key enabler of sustainability. Backed with the aid of using growing
investments, strategic partnerships, and technological breakthroughs,
artificial biology is unexpectedly shaping the destiny of biotechnology.
Have any questions or need more information?
Click the link below to request a sample or make an inquiry before making your
purchase:
https://foreclaroglobalresearch.com/research-report/global-synthetic-biology-market
Global Synthetic
Biology Market Report Highlights
· The
synthetic biology market is experiencing robust growth, driven by upgrades in
DNA sequencing, gene editing (CRISPR), and bioengineering technologies.
· Wide
adoption during healthcare, business biotechnology, food & agriculture, and
environmental sustainability sectors.
· Therapeutics,
vaccine improvement, and drug discovery remain the most important utility
areas, supported through growing personalized medicine.
· Rapid
development in AI-pushed protein design, genome engineering, and bioinformatics
is accelerating product improvement and decreasing costs.
· North
America leads the marketplace, Europe specializes in sustainable bioeconomy
initiatives, whilst Asia-Pacific is the fastest-developing location because of
increasing biotech infrastructure.
· Increasing partnerships, acquisitions, and
investments through biotech companies, study institutes, and authorities our
bodies are fueling innovation and commercialization.
Foreclaro
Global Research has segmented the Synthetic Biology Market report based on Tool,
Technology, Application, End Users, and region:
Synthetic
Biology Market, Tool Outlook (Revenue - USD Million, 2020 - 2033)
Oligonucleotides
and Synthetic DNA
·
Oligonucleotides/Primers
·
Synthetic
Genes
·
DNA
Libraries
Enzymes
·
Polymerases
·
Ligases
·
Nucleases
·
Restriction
Enzymes
Chassis
Organisms
·
Microbial
·
Mammalian
Cells
·
Other
Host Organisms
Software
& Design Tools
·
Bioinformatics
Platforms
·
DNA
Design & Sequencing Software
Synthetic
Biology Market, Technology Outlook (Revenue - USD Million, 2020 - 2033)
Gene
Synthesis
Genome
Engineering
Sequencing
Bioinformatics
Site-Directed
Mutagenesis
Cloning
& Assembly
Microfluidics
Phage
Engineering
Synthetic
Biology Market, Application Outlook (Revenue - USD Million, 2020 - 2033)
Healthcare
·
Therapeutics
·
Drug
Discovery & Development
·
Diagnostics
Industrial
Applications
·
Biofuels
& Renewable Energy
·
Bioplastics
& Bio-based Materials
·
Bio-Manufacturing
Food &
Agriculture
Environmental
Applications
Synthetic
Biology Market, End User Outlook (Revenue - USD Million, 2020 - 2033)
Biotechnology
and Pharmaceutical Companies
Academic
& Research Institutes
Food &
Agricultural Companies
Energy
& Chemical Companies
Contract
Research & Manufacturing Organizations (CROs/CMOs)
Synthetic
Biology Market, Regional Outlook (Revenue - USD Million, 2020 - 2033)
North
America
·
United
States
·
Canada
·
Mexico
Europe
·
United
Kingdom
·
Germany
·
France
·
Spain
·
Italy
·
Rest
of Europe
Asia
Pacific
·
China
·
India
·
Japan
·
Australia
·
South
Korea
·
Rest
of Asia Pacific
Latin
America
·
Brazil
·
Argentina
·
Rest
of Latin America
Middle East
& Africa
·
Saudi
Arabia
·
South
Africa
·
Rest
of MEA
Global Synthetic Biology Market Key Players
·
Bota Biosciences Inc.
·
Codexis, Inc.
·
Creative Biogene.
·
Creative Enzymes.
·
Enbiotix, Inc.
·
Illumina, Inc.
·
Merck Kgaa
·
New England Biolabs
·
Eurofins Scientific
·
Novozymes
